欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:
卡培他滨为基础一线方案治疗Her2阴性转移性乳腺癌的单中心回顾性研究及TYMP基因多态性分析
尹子毅,王 峰,赵 梦,张 铁,王丕琳
Effects of thymidine phosphorylase genetic variation on the prognosis of Her2 negative metastatic breast cancer patients treated with capecitabine based first line chemotherapy
YIN Ziyi, WANG Feng, ZHAO Meng, ZHANG Tie, WANG Pilin
中国临床药理学与治疗学 . 2019, (9): 1002 -1008 .  DOI: 10.12092/j.issn.1009-2501.2019.09.007